Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

61.69 -0.52 (-0.84%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 25, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	6,759,307
Open	61.99
Bid (Size)	60.10 (100)
Ask (Size)	61.50 (4,100)
Prev. Close	62.21
Today's Range	61.42 - 64.00
52wk Range	54.11 - 93.25
Shares Outstanding	390,000,000
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

DXCM INVESTORS: Contact Kirby McInerney LLP About Securities Class Action Lawsuit On Behalf of DexCom, Inc.

Today 18:41 EST

From Kirby McInerney LLP

Via Business Wire

Labaton Keller Sucharow LLP Announces Expanded Securities Class Action Lawsuit Filed Against DexCom, Inc. and Certain Executives

Today 16:41 EST

From Labaton Keller Sucharow LLP

Via Business Wire

Performance

YTD	-21.4%	-21.4%
1 Month	-12.7%	-12.7%
3 Month	-18.8%	-18.8%
6 Month	-27.7%	-27.7%
1 Year	-20.7%	-20.7%

More News

DXCM Class Action Alert: Kessler Topaz Meltzer & Check, LLP Reminds DexCom, Inc. (DXCM) Shareholders of Securities Fraud Class Action Lawsuit Deadline

Today 11:00 EST

Via NewMediaWire

DXCM Class Action Alert: Kessler Topaz Meltzer & Check, LLP Reminds DexCom, Inc. (DXCM) Shareholders of Securities Fraud Class Action Lawsuit Deadline

Today 11:00 EST

Via TheNewswire.com

Levi & Korsinsky Notifies DexCom, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - DXCM

Today 9:15 EST

Via NewMediaWire

Levi & Korsinsky Notifies DexCom, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - DXCM

Today 9:15 EST

Via TheNewswire.com

Elanco, AMN Healthcare Services, Brookdale, DexCom, and Addus HomeCare Shares Skyrocket, What You Need To Know

November 24, 2025

Via StockStory

Lowey Dannenberg Notifies DexCom, Inc. (“DexCom” or the “Company”) (NASDAQ: DXCM) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to Contact the Firm

November 24, 2025

From Lowey Dannenberg, P.C.

Via GlobeNewswire

DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm

November 24, 2025

From Schall Law

Via GlobeNewswire

Shareholders That Lost Money on DexCom, Inc. (DXCM) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More

November 24, 2025

Via NewMediaWire

Shareholders That Lost Money on DexCom, Inc. (DXCM) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More

November 24, 2025

Via TheNewswire.com

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against DexCom, Inc. (NASDAQ: DXCM)

November 24, 2025

From Bernstein Liebhard LLP

Via GlobeNewswire

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages DexCom, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DXCM

November 23, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

2 Healthcare Stocks For Beginner Investors With a 30-Year Time Horizon ↗

November 23, 2025

Via The Motley Fool

Kessler Topaz Meltzer & Check, LLP Notifies DexCom, Inc. Investors of Upcoming Deadline in Securities Fraud Class Action Lawsuit

November 23, 2025

Via NewMediaWire

Kessler Topaz Meltzer & Check, LLP Notifies DexCom, Inc. Investors of Upcoming Deadline in Securities Fraud Class Action Lawsuit

November 23, 2025

Via TheNewswire.com

AbbVie, Biogen, BioMarin Pharmaceutical, DexCom, and Abbott Laboratories Stocks Trade Up, What You Need To Know

November 21, 2025

Via StockStory

DXCM LAWSUIT ALERT: Levi & Korsinsky Notifies DexCom, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

November 21, 2025

Via NewMediaWire

DXCM LAWSUIT ALERT: Levi & Korsinsky Notifies DexCom, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

November 21, 2025

Via TheNewswire.com

DXCM Announcement: Kessler Topaz Meltzer & Check, LLP Encourages DexCom, Inc. (DXCM) Investors to Contact the Firm About Securities Fraud Class Action Lawsuit

November 21, 2025

Via NewMediaWire

DXCM Announcement: Kessler Topaz Meltzer & Check, LLP Encourages DexCom, Inc. (DXCM) Investors to Contact the Firm About Securities Fraud Class Action Lawsuit

November 21, 2025

Via TheNewswire.com

DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm

November 21, 2025

From Schall Law

Via GlobeNewswire

Top 2 Healthcare Stocks Every New Investor Should Know ↗

November 21, 2025

Via The Motley Fool

ROSEN, SKILLED INVESTOR COUNSEL, Encourages DexCom, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DXCM

November 20, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

Levi & Korsinsky Notifies DexCom, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - DXCM

November 20, 2025

Via NewMediaWire

Frequently Asked Questions

Is DexCom, Inc. - Common Stock publicly traded?

Yes, DexCom, Inc. - Common Stock is publicly traded.

What exchange does DexCom, Inc. - Common Stock trade on?

DexCom, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for DexCom, Inc. - Common Stock?

The ticker symbol for DexCom, Inc. - Common Stock is DXCM on the Nasdaq Stock Market

What is the current price of DexCom, Inc. - Common Stock?

The current price of DexCom, Inc. - Common Stock is 61.69

When was DexCom, Inc. - Common Stock last traded?

The last trade of DexCom, Inc. - Common Stock was at 11/25/25 04:00 PM ET

What is the market capitalization of DexCom, Inc. - Common Stock?

The market capitalization of DexCom, Inc. - Common Stock is 24.06B

How many shares of DexCom, Inc. - Common Stock are outstanding?

DexCom, Inc. - Common Stock has 24B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.